© 2002 European Society of Cardiology
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure
a Service de Cardiologie Centre Hospitalier René Dubos 6 avenue d'Ile de France 95300 Pontoise, France
b Service de Cardiologie, Hôpital Européen G. Pompidou Avenue Leblanc 75015 Paris, France
c Service de Cardiologie Hôpital Cochin 24 Bd Saint Jacques 75014 Paris, France
* Corresponding author. Tel.: +33-1-30-75-41-86; fax: +33-1-30-75-44-28 E-mail address: patrickjourdain{at}hotmail.com
 |
Abstract |
|---|
Objectives: To determine if B-type natriuretic peptide (BNP) measurement could be useful in determination of functional capacity in patients suffering from chronic heart failure.
Background: Evaluating functional capacity is a crucial factor in the follow-up of patients with chronic heart failure. There are numerous methods for measuring functional capacity and their relative merits remain under discussion. Clinical classifications are very subjective and other methods are difficult to use in clinical practice.
Methods: We evaluated functional capacity in 151 consecutive patients using the 6-min walk test. All patients were clinically classified using the New York Heart Association (NYHA) classification. We measured BNP plasma levels using a bedside BNP test.
Results: Six minute walk test performance decreased through NYHA classes 1 to 4 (469±87, 411±82, 325±83 and 196±63 m, respectively, P<0.01) and BNP levels increased through NYHA classes 1 to 4 (26.3±7.2, 73±13, 401±74 and 924±84 pg/ml, respectively, P<0.001). There was a significant correlation between 6-min walk test performance and BNP plasma levels (R=0.69 P<0.001) and a weaker correlation between BNP and left ventricular ejection fraction (R=0.45 P<0.04). In some patients there was a mismatch between NYHA classification and 6-min walk test performance. In all cases BNP could correct the clinical estimation of functional capacity. When we divided the patients into three sub-groups within each NYHA class, we showed that using BNP could better define functional capacity in patients suffering from chronic heart failure in NYHA classes I to III.
Conclusion: The measurement of BNP levels thus usefully supplements the clinical examination. The existence of bedside BNP testing methods facilitates its use in routine clinical practice. It also permits easier follow-up of patients with chronic heart failure.
Key Words: B-type natriuretic peptide • Functional capacity • Chronic heart failure • Six minute walk test
Received September 26, 2001; Revised February 21, 2002; Accepted May 1, 2002
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L Frankenstein, A L Clark, K Goode, L Ingle, A Remppis, D Schellberg, F Grabs, M Nelles, J G F Cleland, H A Katus, et al. The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age Heart, May 1, 2009; 95(10): 825 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Donal, M. Roulaud, P. Raud-Raynier, C. De Bisschop, C. Leclercq, G. Derumeaux, J.-C. Daubert, P. Mabo, and A. Denjean Echocardiographic right ventricular strain analysis in chronic heart failure Eur J Echocardiogr, December 1, 2007; 8(6): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. V. Mikkelsen, J. E. Moller, P. Bie, H. Ryde, L. Videbaek, and T. Haghfelt Tei index and neurohormonal activation in patients with incident heart failure: Serial changes and prognostic value Eur J Heart Fail, October 1, 2006; 8(6): 599 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.I. Larsen, K. Dickstein, N.S. Ahmadi, T. Aarsland, J.T. Kvaloy, and C. Hall The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure Eur J Heart Fail, October 1, 2006; 8(6): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Williams, L. L. Ng, R. J. O'Brien, S. Taylor, D. J. Wright, and L.-B. Tan Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study Eur J Heart Fail, December 1, 2004; 6(7): 891 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Cleland and K. Goode Natriuretic peptides for heart failure. Fashionable? Useful? Necessary? Eur J Heart Fail, March 15, 2004; 6(3): 253 - 255. [Full Text] [PDF]
|
|
|
|
|
|
P. Bettencourt NT-proBNP and BNP: biomarkers for heart failure management Eur J Heart Fail, March 15, 2004; 6(3): 359 - 363. [Abstract] [Full Text] [PDF]
|
|